MAI Capital Management - RegeneRx Biopharmaceuticals ownership

RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 2 filers reported holding RegeneRx Biopharmaceuticals in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of RegeneRx Biopharmaceuticals
ValueSharesWeighting
Q2 2022$3,00020,0000.00%
Other shareholders
RegeneRx Biopharmaceuticals shareholders Q2 2022
NameSharesValueWeighting ↓
Williams Jones Wealth Management, LLC. 10,000$1700.00%
View complete list of RegeneRx Biopharmaceuticals shareholders